Nymox Pharmaceutical Corporation (Nasdaq: NYMX) announced the release of positive new clinical trial data from responder analysis of the Company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE